4
Participants
Start Date
January 6, 2019
Primary Completion Date
September 1, 2019
Study Completion Date
September 1, 2019
KB195 (a novel mixture of oligosaccharides)
KB195 (a novel mixture of oligosaccharides) for oral intake for 21 days.
University Children's Hospital Zurich, Zurich
Lead Sponsor
Kaleido Biosciences
INDUSTRY